SCHEMBL30953111

SCHEMBL30953111

CC1CCC([C@H](NC(=O)OC(C)(C)C)C(=O)Nc2cc(COC(=O)NCC(F)(F)F)ccn2)CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 5/20 0.42
▸ MAPT P10636 1/20 0.34
▸ IGF1R P08069 1/20 0.34
▸ MMP1 P03956 1/20 0.34
▸ CCNE1 P24864 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ SCN9A Q15858 1/20 0.34
▸ NR3C2 P08235 2/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ DYRK1A Q13627 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ CACNA1B Q00975 1/20 0.33
▸ CTSL P07711 1/20 0.33
▸ KLK7 P49862 1/20 0.32
▸ KLK5 Q9Y337 1/20 0.32
▸ ACACB O00763 1/20 0.32
▸ ACACA Q13085 1/20 0.32
▸ SYK P43405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30952941 0.91 AAK1 (0.39) AAK1MAPTIGF1RMMP1CCNE1
SCHEMBL27393615 0.84 AAK1 (0.48) AAK1IGF1RMMP1SCN9ANR3C2
SCHEMBL30953221 0.84 AAK1 (0.48) AAK1IGF1RMMP1SCN9ANR3C2
SCHEMBL30953339 0.84 AAK1 (0.50) AAK1IGF1RMMP1NR3C2CDK5
SCHEMBL30953276 0.83 AAK1 (0.44) AAK1IGF1RMMP1NR3C2CDK5
SCHEMBL27393604 0.83 AAK1 (0.44) AAK1IGF1RMMP1NR3C2CDK5
SCHEMBL30953522 0.82 AAK1 (0.47) AAK1IGF1RMMP1CYP3A4NR3C2
SCHEMBL30953440 0.82 AAK1 (0.51) AAK1MMP1ACACBACACA
SCHEMBL30953499 0.82 AAK1 (0.39) AAK1MAPTNR3C2CTSLKLK7
SCHEMBL30953454 0.80 AAK1 (0.43) AAK1IGF1RMMP1CYP3A4SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP claimed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO claimed
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback